Superior Long-Term Survival with Fludarabine-Melphalan RIC Regimen in Older AML/MDS Patients: A Propensity Score Analysis of CIBMTR Data

Authors

• Xia Bi MD, MS, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2026

Volume

32

Issue

2

First Page

53

Last Page

54

Published In/Presented At

https://doi.org/10.1016/j.jtct.2025.12.083

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article